Paper Details

  1. Home
  2. Paper Details

Adverse effects of beta-agonists: are they clinically relevant?

Author: AbramsonMichael J, WaltersE Haydn, WaltersJulia

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

The study reviews the evidence for adverse effects associated with regular use of inhaled beta(2)-adrenoceptor agonists (beta(2)-agonists) in asthma management, focusing on potential risks of asthma deaths, exacerbations, and cardiovascular effects.
Paper Details　
Original Abstract of the Article :
Inhaled beta(2)-adrenoceptor agonists (beta(2)-agonists) are the most commonly used asthma medications in many Western countries. Minor adverse effects such as palpitations, tremor, headache and metabolic effects are predictable and dose related. Time series studies suggested an association between ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/BF03256657

データ提供：米国国立医学図書館（NLM）

Beta-Agonists for Asthma: Navigating the Sand Dunes of Side Effects

Asthma, like a relentless desert wind, can wreak havoc on the respiratory system, leaving individuals struggling for breath. Beta-agonists, a class of medications used to treat asthma, have been a mainstay in respiratory care. However, like all medications, they come with potential side effects, which this study explores in detail.

A Balancing Act: Weighing Benefits and Risks

The study delves into the complex relationship between beta-agonist use and asthma outcomes. While these medications can provide significant relief from asthma symptoms, the researchers highlight the need for careful consideration of potential risks, including an increased risk of asthma exacerbations, near-fatal attacks, and cardiovascular events. This underscores the importance of individualized treatment plans that weigh the benefits of beta-agonists against their potential risks.

Navigating the Terrain: A Personalized Approach to Asthma Care

The desert of asthma management is filled with diverse terrain, requiring a personalized approach to care. This study provides valuable insights into the potential risks and benefits of beta-agonist use, empowering healthcare providers to make informed decisions about the most appropriate treatment strategies for each patient. It is a reminder that a careful balance must be struck between symptom relief and potential side effects, ensuring the safety and well-being of individuals with asthma.

Dr.Camel's Conclusion

This study serves as a cautionary tale, reminding us that even in the seemingly straightforward world of asthma management, the path to optimal care can be filled with complexities. By carefully weighing the benefits and risks of beta-agonists, healthcare providers can guide patients through the desert of asthma, ensuring a more balanced and safe approach to treatment.

Date :
  1. Date Completed 2004-01-30
  2. Date Revised 2019-11-08
Further Info :

Pubmed ID

14719995

DOI: Digital Object Identifier

10.1007/BF03256657

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.